×

Premium Content - Please Submit to Continue:

First Name
Last Name
Company
Thank you!
Error - something went wrong!

Alzheimer's Disease: Detecting Pro-Cognitive Effects in Clinical Drug Trials

March 23, 2015

Recorded Live November 23, 2011

In this video, we discuss the different issues that arise when selecting and implementing cognitive tests in drug trials, the use of cognition testing to make decisions at the Proof of Concept stage of development, and the new requirements for assessing cognition in CNS indications. Our guest speaker is Dr. John Harrison.

Previous
Multiple Sclerosis Clinical Trials: ePRO and eClinRO Best Practices
Multiple Sclerosis Clinical Trials: ePRO and eClinRO Best Practices

Kai Langel and Glenn Gammer discuss the challenges of ePRO in multiple sclerosis clinical trials, and prese...

Next
Advantage of ePRO for Pain Studies
Advantage of ePRO for Pain Studies

Chris Clancy looks at ePRO deployment in three types of pain studies, discussing the advantages and offerin...